Ipswich Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.52M Sell
15,234
-586
-4% -$201K 1.16% 25
2026
Q1
$5.57M Sell
15,820
-230
-1% -$82K 1.31% 24
2025
Q4
$5.25M Sell
16,050
-429
-3% -$136K 1.22% 25
2025
Q3
$4.65M Sell
16,479
-50
-0.3% -$14.5K 1.09% 27
2025
Q2
$4.62M Sell
16,529
-37
-0.2% -$10.5K 1.11% 28
2025
Q1
$5.16M Sell
16,566
-210
-1% -$62K 1.28% 26
2024
Q4
$4.37M Sell
16,776
-1,322
-7% -$392K 1.05% 29
2024
Q3
$5.83M Hold
18,098
1.35% 25
2024
Q2
$5.65M Sell
18,098
-180
-1% -$52.9K 1.32% 26
2024
Q1
$5.2M Sell
18,278
-80
-0.4% -$23.4K 1.22% 26
2023
Q4
$5.29M Sell
18,358
-8
-0% -$2.18K 1.34% 25
2023
Q3
$4.94M Buy
18,366
+125
+0.7% +$31.2K 1.35% 23
2023
Q2
$4.05M Sell
18,241
-254
-1% -$58.9K 1.07% 30
2023
Q1
$4.47M Sell
18,495
-193
-1% -$47.4K 1.22% 25
2022
Q4
$4.91M Sell
18,688
-337
-2% -$90.3K 1.4% 20
2022
Q3
$4.29M Sell
19,025
-672
-3% -$163K 1.36% 21
2022
Q2
$4.79M Sell
19,697
-512
-3% -$125K 1.38% 19
2022
Q1
$4.89M Sell
20,209
-20
-0.1% -$4.59K 1.21% 19
2021
Q4
$4.55M Sell
20,229
-763
-4% -$161K 1.06% 28
2021
Q3
$4.46M Sell
20,992
-968
-4% -$223K 1.14% 23
2021
Q2
$5.35M Sell
21,960
-132
-0.6% -$32.5K 1.37% 18
2021
Q1
$5.5M Buy
22,092
+165
+0.8% +$39.4K 1.55% 15
2020
Q4
$5.04M Sell
21,927
-1,058
-5% -$244K 1.51% 16
2020
Q3
$5.84M Sell
22,985
-169
-0.7% -$41.9K 1.87% 10
2020
Q2
$5.46M Sell
23,154
-838
-3% -$191K 1.88% 11
2020
Q1
$4.86M Sell
23,992
-1,692
-7% -$370K 1.91% 11
2019
Q4
$6.19M Sell
25,684
-155
-0.6% -$34.2K 1.82% 10
2019
Q3
$5M Buy
25,839
+5
+0% +$960 1.59% 15
2019
Q2
$4.76M Buy
25,834
+165
+0.6% +$29.5K 1.52% 15
2019
Q1
$4.88M Buy
25,669
+388
+2% +$74.1K 1.59% 15
2018
Q4
$4.92M Buy
25,281
+1,339
+6% +$261K 1.8% 12
2018
Q3
$4.96M Sell
23,942
-595
-2% -$117K 1.68% 15
2018
Q2
$4.53M Sell
24,537
-195
-0.8% -$34.5K 2.08% 13
2018
Q1
$4.22M Buy
24,732
+177
+0.7% +$32.5K 1.78% 18
2017
Q4
$4.27M Sell
24,555
-490
-2% -$86.7K 1.81% 20
2017
Q3
$4.67M Buy
25,045
+510
+2% +$90.4K 2.1% 13
2017
Q2
$4.23M Sell
24,535
-230
-0.9% -$37.4K 1.98% 15
2017
Q1
$4.06M Sell
24,765
-44
-0.2% -$7.31K 1.77% 19
2016
Q4
$3.63M Buy
24,809
+520
+2% +$78.3K 1.64% 20
2016
Q3
$4.05M Sell
24,289
-445
-2% -$75.3K 1.98% 11
2016
Q2
$3.76M Sell
24,734
-56
-0.2% -$8.71K 1.86% 12
2016
Q1
$3.85M Sell
24,790
-1,040
-4% -$155K 1.83% 11
2015
Q4
$4.19M Buy
25,830
+421
+2% +$66.2K 1.89% 13
2015
Q3
$3.52M Sell
25,409
-602
-2% -$94.9K 1.67% 18
2015
Q2
$3.99M Buy
26,011
+30
+0.1% +$4.81K 1.8% 17
2015
Q1
$4.15M Sell
25,981
-7,621
-23% -$1.2M 1.82% 17
2014
Q4
$5.35M Sell
33,602
-1,215
-3% -$189K 2.28% 10
2014
Q3
$4.89M Sell
34,817
-2,635
-7% -$344K 2.08% 13
2014
Q2
$4.43M Buy
37,452
+405
+1% +$46.9K 1.72% 19
2014
Q1
$4.57M Sell
37,047
-243
-0.7% -$29.5K 1.97% 16
2013
Q4
$4.25M Buy
37,290
+55
+0.1% +$6.26K 1.78% 17
2013
Q3
$4.17M Buy
37,235
+133
+0.4% +$14.4K 1.87% 16
2013
Q2
$3.66M Buy
+37,102
New +$3.85M 1.58% 22

Other funds holding AMGN

Ipswich Investment Management's AMGN Position: Q2 2026 in Review

Ipswich Investment Management reduced its Amgen (AMGN) stake by 3.7% in Q2 2026, selling an estimated $201K and leaving 15,234 shares worth $5.52M. The position accounts for 1.16% of the portfolio, ranked #25.

Ipswich Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.19M in Q4 2019. 1,264 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Ipswich Investment Management held 15,234 shares of Amgen worth $5.52M as of Q2 2026.
  • Ipswich Investment Management sold 586 Amgen shares in Q2 2026, an estimated $201K.
  • Amgen made up 1.16% of Ipswich Investment Management's portfolio in Q2 2026, its #25 holding.
  • Ipswich Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • Ipswich Investment Management's Amgen position peaked at $6.19M in Q4 2019.
  • 1,264 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Ipswich Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.